Details of the Drug Reposition

General Information of This Drug (ID: DMQSC5O)

Drug Name
Varlilumab   DMQSC5O

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Recurrent glioblastoma DISHYPKS 2A00.00 Phase 2 [1]
Colorectal cancer DISNH7P9 2B91.Z Phase 2 [2]
Ovarian cancer DISZJHAP 2C73 Phase 2 [2]
Renal cell carcinoma DISQZ2X8 2C90 Phase 2 [2]
Head and neck cancer DISBPSQZ 2D42 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)